鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

交易中 11-19 13:28:23

11.360

+0.020

+0.18%

最高11.340	最低11.340	成交量3,025
今开11.340	昨收11.340	日振幅0.00%
总市值6.07亿	流通市值6.07亿	总股本5,342万
成交额3.43万	换手率0.01%	流通股本5,342万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":11.36,"timestamp":1731993064399,"preClose":11.34,"halted":0,"volume":3025,"delay":0,"floatShares":53417001,"shares":53417001,"eps":-1.3773897,"marketStatus":"交易中","marketStatusCode":2,"change":0.02,"latestTime":"11-19 13:28:23","open":11.34,"high":11.34,"low":11.34,"amount":34299,"amplitude":0,"askPrice":11.46,"askSize":100,"bidPrice":11.36,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-1.8427009391885583,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732003800000},"adr":0,"listingDate":1636041600000,"adjPreClose":11.34,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.115271,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251/wiki","defaultTab":"wiki","newsList":[{"id":"2481829329","title":"医思健康(02138.HK)出售医疗服务51%  增持医学影像附属余下40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481829329","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481829329?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:52","pubTimestamp":1730908320,"startTime":"0","endTime":"0","summary":"医思健康(02138.HK) 公布，向独立第三方出售医疗服务及医学影像服务附属-New Medical Centre 51%股权，代价4.38亿元。同时，收购医学先进影像服务附属-HKMAI TST余下40%股权至全资拥有，代价1,694万元，拟以内部资源拨资。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210712124043430_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210712124043430_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1394675/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02251","BK1593","BK1189","02138","BK1215","BK1511"],"gpt_icon":0},{"id":"2481564222","title":"鹰瞳科技-B盘中异动 下午盘股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481564222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481564222?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:21","pubTimestamp":1730877718,"startTime":"0","endTime":"0","summary":"2024年11月06日下午盘15时21分，鹰瞳科技-B股票出现波动，股价快速跳水5.83%。截至发稿，该股报10.980港元/股，成交量1300股，换手率0.00%，振幅5.83%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.11%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。该公司的主营业务是提供基于人工智能的视网膜早期检测、诊断和健康风险评估解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110615215898e40c69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110615215898e40c69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2479181088","title":"迈瑞医疗的增长硬逻辑：研发投入再攀高，创新成果助推行业升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479181088","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479181088?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:57","pubTimestamp":1730368628,"startTime":"0","endTime":"0","summary":"10月29日盘后，迈瑞医疗（300760.SZ）发布了2024年第三季度财报，数据显示，公司前三季度营收294.85亿元，同比增长7.99%，归母净利润106.37亿元，同比增长8.16%，剔除汇兑损益影响后同比增长11.00%。分业务来看，体外诊断业务与医学影像业务的增长是公司保持涨势的主要因素，分区域来看，迈瑞医疗在国际市场继续高歌猛进，...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OurQDN9bSGAVhgJguV1rHoI1t6cX0-XyOkpVWO5TQxGUkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OurQDN9bSGAVhgJguV1rHoI1t6cX0-XyOkpVWO5TQxGUkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241031A07RLN00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241031A07RLN00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2478911353","title":"国家药监局：健全支持人工智能和医学影像医疗器械相应产业创新发展机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2478911353","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478911353?lang=zh_cn&edition=full","pubTime":"2024-10-26 11:51","pubTimestamp":1729914713,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02251","09996","BK1583","BK1222","161631","BK1189","09997","159883","BK1574","BK1100"],"gpt_icon":0},{"id":"2476233914","title":"鹰瞳科技-B(02251)：吴浩然获任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2476233914","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476233914?lang=zh_cn&edition=full","pubTime":"2024-10-18 20:14","pubTimestamp":1729253640,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B(02251)发布公告，吴浩然已于临时股东大会上获委任为第二届董事会的...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_16.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_16.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2476013647","title":"慢下来的迈瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2476013647","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476013647?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:30","pubTimestamp":1729132229,"startTime":"0","endTime":"0","summary":"一直保持业绩快速增长的迈瑞医疗，正在慢下来。2024年上半年，迈瑞医疗实现营业收入205.31亿元，同比增长11.12%；实现归母净利润75.61亿元，同比增长17.37%，扣非净利润为73.80亿元，同比增长16.39%。尽管公司营收和归母净利润依旧维持双位数增长，但相比往年来说迈瑞医疗上半年业绩增速放缓明显。自2023年第三季度以来，迈瑞医疗营收增速已经连续4个季度保持在10%上下。回头来看，外部政策冲击成为迈瑞医疗营收降速的一个主要原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/242238","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1189","09996","BK1222","BK1574","BK1583","02251","09997","BK1100"],"gpt_icon":0},{"id":"2475809717","title":"鹰瞳科技-B盘中异动 急速下跌9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475809717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475809717?lang=zh_cn&edition=full","pubTime":"2024-10-14 10:00","pubTimestamp":1728871242,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘10时00分，鹰瞳科技-B股票出现异动，股价大幅下挫9.11%。截至发稿，该股报10.180港元/股，成交量3700股，换手率0.01%，振幅8.21%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.24%。其相关个股中，心玮医疗-B、GUANZE MEDICAL、加和国际控股涨幅较大，振幅较大的相关个股有GUANZE MEDICAL、巨星医疗控股、微创机器人-B，振幅分别为11.32%、10.96%、9.94%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014100043a1e063d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014100043a1e063d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2474059253","title":"没有涨跌停限制，新股被爆炒！超声“鼻祖”提交创业板注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2474059253","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474059253?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:04","pubTimestamp":1728439442,"startTime":"0","endTime":"0","summary":"4年累计分红超3亿","market":"us","thumbnail":"https://img3.gelonghui.com/534e4-a56e8d73-bf97-4f84-b073-034847e7c718.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/534e4-a56e8d73-bf97-4f84-b073-034847e7c718.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1132457","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2473060463","title":"鹰瞳科技-B盘中异动 早盘快速跳水5.02%报11.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473060463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473060463?lang=zh_cn&edition=full","pubTime":"2024-10-08 10:00","pubTimestamp":1728352807,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘10时00分，鹰瞳科技-B股票出现异动，股价快速跳水5.02%。截至发稿，该股报11.720港元/股，成交量1.24万股，换手率0.02%，振幅8.75%。资金方面，该股资金流入3.9572万港元，流出11.0808万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.45%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081000079719ecf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081000079719ecf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2473441140","title":"鹰瞳科技-B(02251)上涨5.26%，报12.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473441140","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473441140?lang=zh_cn&edition=full","pubTime":"2024-10-07 14:28","pubTimestamp":1728282492,"startTime":"0","endTime":"0","summary":"10月7日，鹰瞳科技-B(02251)盘中上涨5.26%，截至14:28，报12.0元/股，成交100.38万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2024年中报，鹰瞳科技-B营业总收入9371.0万元、净利润-8050.2万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/07142843738060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2473116291","title":"鹰瞳科技-B盘中异动 股价大涨5.09%报11.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473116291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473116291?lang=zh_cn&edition=full","pubTime":"2024-10-07 09:33","pubTimestamp":1728264839,"startTime":"0","endTime":"0","summary":"2024年10月07日早盘09时33分，鹰瞳科技-B股票出现波动，股价快速上涨5.09%。截至发稿，该股报11.980港元/股，成交量6000股，换手率0.01%，振幅2.46%。资金方面，该股资金流入6.588万港元，流出5850港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.10%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007093359ab6804f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007093359ab6804f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2472661605","title":"鹰瞳科技-B盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472661605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472661605?lang=zh_cn&edition=full","pubTime":"2024-10-04 10:39","pubTimestamp":1728009568,"startTime":"0","endTime":"0","summary":"2024年10月04日早盘10时39分，鹰瞳科技-B股票出现波动，股价大幅上涨5.73%。截至发稿，该股报11.800港元/股，成交量1700股，换手率0.00%，振幅1.61%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.16%。其相关个股中，心玮医疗-B、佳兆业健康、巨星医疗控股涨幅较大，振幅较大的相关个股有紫元元、佳兆业健康、心玮医疗-B，振幅分别为16.14%、13.51%、10.76%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004103929a1de3c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004103929a1de3c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2472557872","title":"鹰瞳科技-B盘中异动 早盘股价大涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472557872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472557872?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:36","pubTimestamp":1727832975,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘09时36分，鹰瞳科技-B股票出现异动，股价大幅上涨5.75%。截至发稿，该股报11.040港元/股，成交量5000股，换手率0.01%，振幅0.57%。资金方面，该股资金流入7350港元，流出4.533万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.05%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002093615ab676266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002093615ab676266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2471779829","title":"鹰瞳科技-B(02251)下跌5.79%，报11.06元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471779829","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471779829?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:20","pubTimestamp":1727680827,"startTime":"0","endTime":"0","summary":"9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2024年中报，鹰瞳科技-B营业总收入9371.0万元、净利润-8050.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/30152043653949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2471829235","title":"鹰瞳科技-B盘中异动 下午盘股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471829235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471829235?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:20","pubTimestamp":1727680821,"startTime":"0","endTime":"0","summary":"2024年09月30日下午盘15时20分，鹰瞳科技-B股票出现异动，股价大幅下跌5.79%。截至发稿，该股报11.060港元/股，成交量13.51万股，换手率0.25%，振幅9.54%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.73%。其相关个股中，微创机器人-B、微创医疗、智云健康涨幅较大，振幅较大的相关个股有佳兆业健康、微创机器人-B、微创医疗，振幅分别为45.45%、23.79%、21.70%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093015202198e39cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093015202198e39cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2470714595","title":"鹰瞳科技-B盘中异动 早盘快速拉升9.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470714595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470714595?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:36","pubTimestamp":1727401011,"startTime":"0","endTime":"0","summary":"2024年09月27日早盘09时36分，鹰瞳科技-B股票出现波动，股价大幅上涨9.46%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.06%。其相关个股中，微创机器人-B、鹰瞳科技-B、复锐医疗科技涨幅较大，振幅较大的相关个股有微创机器人-B、智云健康、高视医疗，振幅分别为10.03%、6.67%、5.48%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092709365198e393b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092709365198e393b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2470240243","title":"鹰瞳科技-B盘中异动 股价大涨5.90%报11.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470240243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470240243?lang=zh_cn&edition=full","pubTime":"2024-09-26 10:02","pubTimestamp":1727316155,"startTime":"0","endTime":"0","summary":"2024年09月26日早盘10时02分，鹰瞳科技-B股票出现异动，股价大幅拉升5.90%。截至发稿，该股报11.480港元/股，成交量2000股，换手率0.00%，振幅1.11%。资金方面，该股资金流入2.2896万港元，流出0港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.00%。其相关个股中，紫元元股权、紫元元、鹰瞳科技-B涨幅较大，振幅较大的相关个股有紫元元股权、紫元元、佳兆业健康，振幅分别为84.62%、22.97%、5.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092610023598e38f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092610023598e38f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2469964182","title":"鹰瞳科技-B建议委任吴浩然为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2469964182","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469964182?lang=zh_cn&edition=full","pubTime":"2024-09-23 07:50","pubTimestamp":1727049058,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B（02251）发布公告，于2024年9月20日举行的会议上，董事会议决（i）于公司应届临时股东大会上建议委任吴浩然为第二届董事会的独立非执行董事，以供股东审议及批准，及（ii）委任吴先生为审核委员会主席以及薪酬与考核委员会及战略委员会的成员（待吴先生获股东批准委任为独立非执行董事后方可作实）。委任吴先生为审核委员会主席、薪酬与考核委员会及战略委员会的成员将于临时股东大会上获股东批准其获委任为独立非执行董事后生效。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-09-23/doc-incqawvz5395030.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-09-23/doc-incqawvz5395030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2468778621","title":"鹰瞳科技-B(02251)建议委任吴浩然为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2468778621","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468778621?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:22","pubTimestamp":1726842158,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B(02251)发布公告，于2024年9月20日举行的会议上，董事会议决...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2466487817","title":"Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)1.75万股 每股作价约10.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466487817","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466487817?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:26","pubTimestamp":1725960360,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，9月9日，Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)1.75万股，每股作价10.9945港元，总金额约为19.24万港元。增持后最新持股数目为962.56万股，最新持股比例为18.02%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-09-10/doc-incnsiqi7811855.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-09-10/doc-incnsiqi7811855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02251","BK1189"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0053},{"period":"1month","weight":0.0216},{"period":"3month","weight":-0.0139},{"period":"6month","weight":-0.2539},{"period":"1year","weight":0.0272},{"period":"ytd","weight":-0.0628}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司。该公司的主营业务是提供基于人工智能的视网膜早期检测、诊断和健康风险评估解决方案。该公司主要产品为Airdoc-AIFUNDUS 1.0。该公司的产品可用于青光眼、白内障、ICVD和ASCVD、妊娠糖尿病视网膜病变、妊娠高血压视网膜病变等疾病的诊断 此外，该公司还开发了一系列其他医疗器械软件 (SaMD) 和健康风险评估解决方案，以满足包括医院、社区诊所、健康检查中心、保险公司在内的全人群的各种医疗保健需求。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.073644},{"month":2,"riseRate":0.666667,"avgChangeRate":0.108607},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.093871},{"month":4,"riseRate":0,"avgChangeRate":-0.051106},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.112317},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.004367},{"month":7,"riseRate":0,"avgChangeRate":-0.070414},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.035493},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.077379},{"month":10,"riseRate":0.333333,"avgChangeRate":0.00463},{"month":11,"riseRate":1,"avgChangeRate":0.160045},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.152753}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}